Speaker illustration

Doctor Emel Kaplan

University Hospital Basel, Basel (Switzerland)

Member of:

European Society of Cardiology

Dr Emel (Eliza) Kaplan, MD, PhD, FESC, is an attending cardiologist at University Hospital Basel and co-leads the Women’s Heart Health Program in Basel (since 2024). She is a senior clinical researcher at the Cardiovascular Research Institute Basel and has a background in interventional cardiology. She received her MD from Radboud University (the Netherlands) and conducted her doctoral research at Beth Israel Deaconess Medical Center, Boston (Harvard Medical School). Her clinical and research focus is sex- and gender-specific cardiovascular medicine, particularly INOCA/MINOCA, coronary microvascular dysfunction, and syncope risk stratification and prognosis, including biomarker-based diagnostics. She co-leads the BRAVE brain–heart microvascular project, serves on the ESC Gender Task Force and is a founding member of the Swiss Women’s Heart Board.

From benign to significant: adverse outcomes in patients with first degree AV block and syncope

Event: ESC Congress 2025

Topic: Atrioventricular (AV) Block

Session: Vasovagal syncope: a reflex gone rogue

Thumbnail

False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study

Event: ESC Congress 2024

Topic: Biomarkers

Session: Cardiovascular risk assessment

Thumbnail

Sex-specific syncope characteristics in the early diagnosis of cardiac syncope

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Diagnosis and treatment of syncope and atrioventricular block

Thumbnail

ESC 365 is supported by